Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARIX CORD 1K in Robot-Assisted Radical Prostatectomy
NCT04263025Phase 3Active, not recruiting
- Sponsor
- Hackensack Meridian Health
- Start
- Jan 2020
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 3 trial of CLARIX CORD 1K in prostate cancer (PCa), sponsored by Hackensack Meridian Health. Started Jan 2020; status: active, not recruiting.
02
Drugs
CLARIX CORD 1K
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04263025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04263025.